Aclarion, Inc. has updated the enrollment criteria for its CLARITY clinical trial to better reflect real-world chronic low back pain patients and accelerate patient recruitment. The revised criteria, approved at most active sites, expand the pool of eligible patients while maintaining scientific rigor. This change is expected to speed up enrollment without extending the overall trial duration, with an update on initial readout timing planned by year-end. The CLARITY trial tests Aclarion's Nociscan platform, which helps identify painful discs in the lumbar spine noninvasively, aiming to improve treatment outcomes for chronic low back pain sufferers.
Aclarion's update on the CLARITY trial enrollment criteria is presented here with Pluang's Health-sector market data for context. For readers following Health-sector stocks, 25 out of 100 priced US stocks rose while 68 fell. Notable movers include CTXR at USD 0.50 with a 1-day change of -1.57% and 90% buy orders, CRSP at USD 51.54 down 1.55% with 76% buy orders, and GSK at USD 46.34 down 1.45% with 100% buy orders. These figures are as of Oct 08, 2026 18:11 WIB.
Zscaler CEO Jay Chaudhry has sold 2,852 shares of the company, generating $550,000 from the transaction. This sale could indicate personal financial planning or portfolio rebalancing by the CEO. Investors might watch for any further insider activity ...
Ascentis Independent Advisors has expanded by adding four advisory teams from Raymond James Financial Services, bringing over $1 billion in client assets. These teams, based in California and Colorado, chose Ascentis to access enhanced planning, inve...
Kaskela Law is investigating whether the $32.50 per share buyout price offered to Baldwin Group shareholders by Sequence Holdings and DFO Management is fair. The buyout will end public trading of Baldwin shares, but some analysts had valued the stock...
Netflix shares have fallen 26% in 2026 despite revenue growth, with Q2 revenue up 13.4% to $12.56 billion and strong operating margins. A largely overlooked part of its business—advertising and gaming—is expected to nearly double ad revenue to $3 bil...
Agree Realty and Realty Income both pay monthly dividends and own net lease properties, but Agree Realty is favored for long-term retirement investing. Agree offers stronger dividend coverage, with a payout at about 70% of adjusted funds from operati...
